4.6 Article

Fibroblast α11β1 Integrin Regulates Tensional Homeostasis in Fibroblast/A549 Carcinoma Heterospheroids

Journal

PLOS ONE
Volume 9, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0103173

Keywords

-

Funding

  1. Research council of Norway [183258, 197066]
  2. Norwegian Centre of Excellence grant [223250]
  3. Norwegian cancer society [536711, 3292722]

Ask authors/readers for more resources

We have previously shown that fibroblast expression of alpha 11 beta 1 integrin stimulates A549 carcinoma cell growth in a xenograft tumor model. To understand the molecular mechanisms whereby a collagen receptor on fibroblast can regulate tumor growth we have used a 3D heterospheroid system composed of A549 tumor cells and fibroblasts without (alpha 11(+/+)) or with a deletion (alpha 11(-/-)) in integrin alpha 11 gene. Our data show that alpha 11(-/-)/A549 spheroids are larger than alpha 11(+/+)/A549 spheroids, and that A549 cell number, cell migration and cell invasion in a collagen I gel are decreased in alpha 11(-/-)/A549 spheroids. Gene expression profiling of differentially expressed genes in fibroblast/A549 spheroids identified CXCL5 as one molecule down-regulated in A549 cells in the absence of alpha 11 on the fibroblasts. Blocking CXCL5 function with the CXCR2 inhibitor SB225002 reduced cell proliferation and cell migration of A549 cells within spheroids, demonstrating that the fibroblast integrin alpha 11 beta 1 in a 3D heterospheroid context affects carcinoma cell growth and invasion by stimulating autocrine secretion of CXCL5. We furthermore suggest that fibroblast alpha 11 beta 1 in fibroblast/A549 spheroids regulates interstitial fluid pressure by compacting the collagen matrix, in turn implying a role for stromal collagen receptors in regulating tensional hemostasis in tumors. In summary, blocking stromal alpha 11 beta 1 integrin function might thus be a stroma-targeted therapeutic strategy to increase the efficacy of chemotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available